Soyez, Berenice
Borie, Raphael http://orcid.org/0000-0002-9906-0024
Menard, Cedric
Cadranel, Jacques
Chavez, Leonidas
Cottin, Vincent
Gomez, Emmanuel
Marchand-Adam, Sylvain
Leroy, Sylvie
Naccache, Jean-Marc
Nunes, Hilario
Reynaud-Gaubert, Martine
Savale, Laurent
Tazi, Abdellatif
Wemeau-Stervinou, Lidwine
Debray, Marie-Pierre
Crestani, Bruno
Funding for this research was provided by:
Fondation du Souffle
Article History
Received: 7 February 2018
Accepted: 16 April 2018
First Online: 25 April 2018
Ethics approval and consent to participate
: The Institutional Review Board of the French-learned society for respiratory medicine (Société de Pneumologie de Langue Française) approved this retrospective study (CEPRO 2012–016).
: All patients consent to publication.
: RB reports personal fees and grants from Savarapharma, Roche and Boerhinger Ingelheim. JC reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Novartis, personal fees from Roche, grants and personal fees from Astra Zeneca, grants and personal fees from Pfizer, personal fees from Lilly, personal fees from BMS, outside the submitted work;. VC reports personal fees from Actelion, personal fees from Boehringer Ingelheim, personal fees from Bayer, personal fees from Biogen Idec, personal fees from Gilead, personal fees from GSK, personal fees from MSD, personal fees from Novartis, personal fees from Roche, personal fees from Sanofi, grants from Boehringer Ingelheim, grants from Roche, personal fees from Promedior, personal fees from Celgene, personal fees from Galapagos, outside the submitted work. EG reports non financial support from Actélion, Roche, Boehringer Ingelheim. LS reports grants, personal fees and non-financial support from Actelion, grants, personal fees and non-financial support from Bayer, grants, personal fees and non-financial support from GSK, grants, personal fees and non-financial support from MSD, outside the submitted work;. MPD reports personal fees from Roche and Boehringer-Ingelheim, non financial support from Astrazeneca, General Electric and Guerbet. BC reports grants and personal fees from Boehringer Ingelheim, personal fees from Roche, personal fees from Sanofi, personal fees from Apellis, personal fees from Astra-Zeneca, grants from MedImmune, outside the submitted work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.